Guidance on patient consultation. Current evidence for prostate-specific antigen screening in healthy men and treatment options for men with proven localised prostate cancer

Current Urology Reports
Giovannalberto PiniPeter Wiklund

Abstract

The main objective of this review is to summarise, for primary and secondary care doctors, the management options and current supporting evidence for clinically localised prostate cancer. We review all aspects of management including current guidelines on early cancer detection and the importance of informed consent on PSA-based screening and assess the most common treatment options and the evidence for managing patients with low-, medium-, and high-risk disease.

References

Jun 15, 1982·International Journal of Cancer. Journal International Du Cancer·R YataniP Correa
Jan 27, 1994·The New England Journal of Medicine·G W ChodakJ Warner
Aug 10, 2000·Medical Decision Making : an International Journal of the Society for Medical Decision Making·A EdwardsN Stott
Jun 26, 2003·The New England Journal of Medicine·Ian M ThompsonCharles A Coltman
May 28, 2004·The New England Journal of Medicine·Ian M ThompsonCharles A Coltman
Jun 10, 2004·JAMA : the Journal of the American Medical Association·Jan-Erik JohanssonHans-Olov Adami
Jan 9, 2007·Cancer Causes & Control : CCC·Dragan IlicTimothy Wilt
Dec 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pascal PommierChristian Carrie
Jan 24, 2008·JAMA : the Journal of the American Medical Association·Anthony V D'AmicoPhilip W Kantoff
Jan 14, 2009·Nature Clinical Practice. Urology·Stacy Loeb, William J Catalona
Jul 21, 2009·International Journal of Radiation Oncology, Biology, Physics·Gustavo Arruda VianiSergio Luis Afonso
Sep 2, 2009·Journal of the National Cancer Institute·H Gilbert Welch, Peter C Albertsen
Sep 26, 2009·Clinical Chemistry and Laboratory Medicine : CCLM·Carsten StephanKlaus Jung
Nov 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Laurence KlotzAndrew Loblaw
Feb 18, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael J ZelefskyPeter T Scardino
Apr 2, 2010·The New England Journal of Medicine·Gerald L AndrioleUNKNOWN REDUCE Study Group
May 6, 2011·The New England Journal of Medicine·Anna Bill-AxelsonUNKNOWN SPCG-4 Investigators
Feb 15, 2012·International Journal of Radiation Oncology, Biology, Physics·Michael J ZelefskyMargie Hunt
Feb 24, 2012·Current Opinion in Urology·Roderick C N van den BerghChris H Bangma
Mar 20, 2012·European Urology·Melissa M CenterFreddie Bray
Jul 17, 2012·International Journal of Radiation Oncology, Biology, Physics·Daniel E SprattMichael J Zelefsky

❮ Previous
Next ❯

Citations

Jun 22, 2016·Current Opinion in Urology·Sigrid V Carlsson, Monique J Roobol

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.